What diseases are positive for anti-CCP?

Anti-CCP antibodies are highly specific for rheumatoid arthritis, with 95-98% specificity. Rarely, other autoimmune conditions like certain types of lupus or psoriatic arthritis may cause elevated levels, but rheumatoid arthritis remains by far the most common association.

What is a good CCP level?

The best anti-CCP level is as close to undetectable as possible — well below the 20 EU/mL cutoff. This indicates no current autoimmune activity against joint proteins and very low risk of developing rheumatoid arthritis.

What if anti-CCP is less than 5?

Anti-CCP levels well below the cutoff are reassuring and indicate optimal immune function regarding joint health. This strongly suggests you don't have rheumatoid arthritis and are unlikely to develop it in the near term.

Is a rheumatoid factor of 300 high?

A rheumatoid factor of 300 is significantly elevated (normal is typically below 20 IU/mL). High RF levels, especially when combined with positive anti-CCP antibodies, strongly suggest rheumatoid arthritis and indicate need for immediate evaluation by a rheumatologist.

How stable are anti-CCP antibody levels over time?

Anti-CCP antibody levels tend to be relatively stable once established, unlike inflammatory markers that fluctuate with infection or stress. This stability makes anti-CCP particularly useful for tracking autoimmune progression over time, where trends provide more insight than any single result.

What other biomarkers should be checked alongside anti-CCP?

Anti-CCP testing is most informative when paired with rheumatoid factor, inflammatory markers like CRP and ESR, and sometimes genetic testing for HLA-DRB1 shared epitope alleles. Having both anti-CCP antibodies and susceptibility genes significantly raises rheumatoid arthritis probability compared to either marker alone.

Is anti-CCP testing useful even when joint symptoms are absent?

Yes. Anti-CCP antibodies can appear 5–10 years before clinical symptoms develop, making testing valuable for people with a family history of rheumatoid arthritis even when they feel well. Early identification allows proactive monitoring and lifestyle interventions before irreversible joint damage occurs.

Anti CCP Test Normal Range: Results & Interpretation

Understand what your general health testing results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

What the anti-CCP test measures

Standard laboratory reference ranges define a normal anti-CCP result as below 20 EU/mL (or U/mL), though cutoffs vary by lab.

The anti-CCP test detects antibodies your immune system creates when it mistakes citrullinated proteins for foreign invaders. Citrullination is a normal process where the amino acid arginine gets converted to citrulline in proteins. In healthy people, this happens during inflammation or tissue repair without triggering an immune response.

But in some individuals, the immune system recognizes these citrullinated proteins as threats. It produces anti-CCP antibodies to attack them. Since joint tissues contain high levels of citrullinated proteins, these antibodies primarily target joint cartilage, synovial fluid, and surrounding tissues.

This makes anti-CCP testing remarkably specific for rheumatoid arthritis. Unlike other autoimmune markers that can be elevated in multiple conditions, anti-CCP antibodies are found almost exclusively in people with rheumatoid arthritis or those who will develop it.

The test measures antibody concentration in enzyme units per milliliter (EU/mL). Most commercial anti-CCP2 ELISA assays use similar reference ranges, making results broadly comparable across different testing facilities. This consistency helps track changes over time and compare results from different care teams.

Normal versus optimal anti-CCP levels

Optimal levels from a preventive health perspective would be as close to undetectable as possible. Results well below the cutoff, especially undetectable ones, are the most reassuring. The common 20 U/mL scale has no equivocal band: anything below the cutoff reads as negative.

Whether subthreshold anti-CCP levels in otherwise healthy individuals carry clinical significance remains an active research question, though some evidence suggests even low-titer antibodies may warrant monitoring.

Anti-CCP antibodies are uncommon in healthy individuals — roughly 1-3% of people without rheumatoid arthritis test positive. Those with detectable but "normal" levels represent a mixed group. Some may develop rheumatoid arthritis within years, others may have transient antibody production that resolves, and still others may maintain stable low levels without ever developing disease.

Your individual trend matters more than where you fall within the normal range. Stable low levels over time suggest less concern than gradually rising levels, even if they remain within normal limits.

What a positive result means

Anti-CCP level (U/mL)	Result
Below 20	Negative
20 to 39	Weak positive
40 to 59	Positive (moderate)
60 or higher	Strong positive

These tiers follow the assay manufacturer's classification of positive results. Some assays use other cutoffs, such as 17 U/mL for a positive result.

A positive result is strongly associated with rheumatoid arthritis. The higher the level, the greater the likelihood of having or developing the condition, and the highest levels often come with more aggressive joint involvement. For next steps after a positive result, see the guide to a positive anti-CCP test.

Importantly, anti-CCP antibodies can appear 5-10 years before clinical symptoms develop. This means you might test positive while feeling completely healthy. Studies show that people with high anti-CCP levels are at substantially elevated risk of developing rheumatoid arthritis within 5-10 years, even without current joint symptoms.

High levels are also linked to more severe disease progression. People with elevated anti-CCP antibodies tend to develop more joint erosions, require more aggressive treatment, and have greater functional limitations than those with seronegative rheumatoid arthritis (negative for both anti-CCP and rheumatoid factor).

Rarely, other autoimmune conditions can cause elevated anti-CCP levels. These include certain types of lupus, psoriatic arthritis, or other inflammatory joint conditions. However, the specificity for rheumatoid arthritis remains very high, around 95-98%.

What a negative result means

Anti-CCP levels well below the cutoff are ideal and indicate no current autoimmune activity against citrullinated proteins. This strongly suggests you don't have rheumatoid arthritis and are unlikely to develop it, at least in the near term.

Unlike many biomarkers where "low" might indicate deficiency, there's no such thing as anti-CCP levels that are "too low." These antibodies shouldn't exist in healthy individuals, so undetectable levels represent optimal immune function regarding joint health.

However, it's worth noting that about 20-30% of people with rheumatoid arthritis are "seronegative," meaning they test negative for both anti-CCP and rheumatoid factor antibodies. So normal anti-CCP levels don't completely rule out rheumatoid arthritis if you have suggestive symptoms like morning joint stiffness, symmetrical joint pain, or family history.

A low or negative result doesn't guarantee you'll never develop rheumatoid arthritis. While uncommon, some people can develop antibodies later in life, particularly after infections, significant stress, or hormonal changes. This is why periodic retesting makes sense for those with strong family histories or other risk factors.

How the anti-CCP test is done

The anti-CCP test requires a standard blood draw from a vein, typically in your arm. No special preparation is needed. You don't need to fast, avoid medications (unless specifically instructed by your care team), or make any dietary changes before testing.

Most labs use enzyme-linked immunosorbent assay (ELISA) technology to measure anti-CCP antibodies. This method is highly standardized, which is why reference ranges are broadly consistent across different laboratories. Results are usually available within 1-3 business days.

For people with normal results but strong rheumatoid arthritis risk factors, retesting every 2-3 years makes sense. Those with family history, certain genetic markers (like HLA-DRB1 shared epitope alleles, including HLA-DR4 subtypes), or other autoimmune conditions might benefit from more frequent monitoring.

Results near the cutoff can read weak positive on one assay and negative on another, so if yours sits close to 20 U/mL, your care team might recommend retesting in 6-12 months to see if levels are rising, stable, or declining. Trend analysis provides much more information than a single result.

The test is often ordered alongside rheumatoid factor, inflammatory markers like CRP or ESR, and sometimes genetic testing for rheumatoid arthritis susceptibility genes. This panel approach gives a more complete picture of autoimmune risk.

What can change anti-CCP levels

Anti-CCP antibody levels tend to be relatively stable once established. Unlike inflammatory markers that fluctuate with infection or stress, anti-CCP levels typically remain consistent unless underlying autoimmune processes change.

Certain infections, particularly those affecting the respiratory tract or gut, might temporarily trigger antibody production in susceptible individuals. Smoking significantly increases both the likelihood of developing anti-CCP antibodies and the risk of progressing to rheumatoid arthritis. The combination of smoking and genetic susceptibility creates particularly high risk.

Hormonal changes, especially during pregnancy or menopause, can influence autoimmune activity. Pregnancy is associated with temporary improvement in rheumatoid arthritis disease activity, often followed by a postpartum flare as the immunomodulatory changes of pregnancy subside.

Periodontal disease is strongly linked to anti-CCP antibody development. The bacteria associated with severe gum disease can trigger citrullination processes that lead to antibody production. Maintaining excellent dental health might help reduce the risk of antibody development in susceptible individuals.

Lifestyle factors like chronic stress may influence overall immune activity, though direct effects on anti-CCP levels are not well established. Acute stress, by contrast, tends to produce short-term, transient immune changes rather than sustained antibody shifts.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Anti-CCP testing is most informative when interpreted alongside rheumatoid factor (RF), another antibody associated with rheumatoid arthritis. About 70% of people with rheumatoid arthritis are positive for both markers, while others may be positive for just one. Having both antibodies indicates higher disease severity and more aggressive progression.

Inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) help assess current inflammation levels. People with positive anti-CCP antibodies and elevated inflammatory markers are more likely to have active disease than those with antibodies alone.

Complete blood count (CBC) results can reveal anemia or other blood out-of-range values common in rheumatoid arthritis. Complement levels (C3, C4) may be consumed during active autoimmune processes, providing additional context for antibody results.

Genetic testing for HLA-DRB1 shared epitope alleles (including HLA-DR4 subtypes) can help stratify risk, especially in people with equivocal antibody results. Having both anti-CCP antibodies and susceptibility genes significantly increases rheumatoid arthritis probability.

Vitamin D status might also be relevant. A large randomized trial (VITAL) found that vitamin D supplementation reduced incident autoimmune disease by about 22% over five years, suggesting vitamin D status may influence autoimmune risk. While not directly related to anti-CCP interpretation, optimizing vitamin D status might help modulate immune function in susceptible individuals.